Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Catalano

Showing results (421-430 of 431) with videos related to

Pageof 44
Sort By:
Diabetologia|January 17, 2019
Maternal glucose levels during pregnancy and childhood adiposity in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up StudyWilliam L Lowe, Lynn P Lowe, Alan Kuang, et al.
Obstetrics and Gynecology|July 12, 2018
Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases WorkshopDeborah J Wexler, Camille E Powe, Linda A Barbour, et al.
Controlled Clinical Trials|October 1, 1996
Trial of Calcium for Preeclampsia Prevention (CPEP): rationale, design, and methodsR J Levine, J R Esterlitz, E G Raymond, et al.
Translational Neurodegeneration|May 12, 2023
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheterKelsie M LaBarbera, Yvette I Sheline, Nicholas J Izzo, et al.
JAMA|September 13, 2018
Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood AdiposityWilliam L Lowe, Denise M Scholtens, Lynn P Lowe, et al.
Diabetes Care|May 1, 2008
Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for careJohn L Kitzmiller, Jennifer M Block, Florence M Brown, et al.
Plos One|November 13, 2014
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficitsNicholas J Izzo, Agnes Staniszewski, Lillian To, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2013
Mouse model implicates GNB3 duplication in a childhood obesity syndromeIan S Goldlust, Karen E Hermetz, Lisa M Catalano, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 9, 2021
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modificationNicholas J Izzo, Carla M Yuede, Kelsie M LaBarbera, et al.
Acta Neuropathologica|February 6, 2024
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's diseaseMartí Colom-Cadena, Jamie Toombs, Elizabeth Simzer, et al.
Pageof 44

Showing results (421-430 of 431) with videos related to

Sort By:
Pageof 44
Diabetologia|January 17, 2019
Maternal glucose levels during pregnancy and childhood adiposity in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up StudyWilliam L Lowe, Lynn P Lowe, Alan Kuang, et al.
Obstetrics and Gynecology|July 12, 2018
Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases WorkshopDeborah J Wexler, Camille E Powe, Linda A Barbour, et al.
Controlled Clinical Trials|October 1, 1996
Trial of Calcium for Preeclampsia Prevention (CPEP): rationale, design, and methodsR J Levine, J R Esterlitz, E G Raymond, et al.
Translational Neurodegeneration|May 12, 2023
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheterKelsie M LaBarbera, Yvette I Sheline, Nicholas J Izzo, et al.
JAMA|September 13, 2018
Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood AdiposityWilliam L Lowe, Denise M Scholtens, Lynn P Lowe, et al.
Diabetes Care|May 1, 2008
Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for careJohn L Kitzmiller, Jennifer M Block, Florence M Brown, et al.
Plos One|November 13, 2014
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficitsNicholas J Izzo, Agnes Staniszewski, Lillian To, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2013
Mouse model implicates GNB3 duplication in a childhood obesity syndromeIan S Goldlust, Karen E Hermetz, Lisa M Catalano, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 9, 2021
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modificationNicholas J Izzo, Carla M Yuede, Kelsie M LaBarbera, et al.
Acta Neuropathologica|February 6, 2024
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's diseaseMartí Colom-Cadena, Jamie Toombs, Elizabeth Simzer, et al.
Pageof 44